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ABSTRACT 
Helicobacter pylori (H. pylori) is a human pathogen causing chronic gastritis, gastric 
and duodenal ulcer, gastric carcinoma and dyspepsia. The diagnosis of H. pylori is an 
essential element in the management of these gastrointestinal pathologies. There are 
several invasive and noninvasive methods for diagnosis of Helicobacter pylori 
infection. The plethora of diagnostic tests available for the presence of H. pylori 
indicates that none of them is 100% accurate. Invasive methods requiring endoscopic 
evaluation include bacteriologic culture, histopathological studies, smear examination, 
rapid urease test or CLO test and molecular methods. Noninvasive approaches include 
serological testing, stool antigen detection and urea breath testing. The stool antigen 
test is convenient, non-invasive, and does not require the use of expensive equipment 
or medical personnel. Furthermore, stool can be collected in a patient's home and 
transferred to the hospital or laboratory. 
The aim of the present study was to evaluate the efficacy of H. pylori stool antigen 
detection test (HpSA) in comparison with RUT and serological test. 
The present study was carried out on 92 adult patients suffering from dyspepsia and 
stool samples were examined from another 31 infants as control. From the patients, 
gastric biopsy specimens were taken for detection of H. pylori infection by rapid 
urease test (RUT). In addition, stool samples were taken for the detection of H. pylori 
antigen and blood samples for detection of anti- H. pylori IgA and IgG antibodies. 
Among 92 adult patients undergone endoscopic examination, 19 were found having 
ulcer and 73 were found having erosion. Out of 19 ulcer cases, RUT positive cases 
were 10 (52.63%) and among 73 erosion cases, 30 (41.09%) cases were RUT 
positive.  H. pylori infection was detected in total 40 (43.48%) cases by RUT. Among 
19 ulcer cases, 14 (73.68%) cases were positive for HpSA and 44 (60.27%) cases 
were positive for HpSA out of 73 erosion cases. A total 58 (63.04%) cases were 
HpSA positive with a sensitivity and specificity of 100% and 96.77% respectively. 
Serum anti H. pylori IgA and IgG antibodies were present in 58 (63.04%) and 89 
(96.74%) cases respectively. Both antibodies were present in 57 (61.96%) cases. 
Among 40 RUT positive cases, IgG and IgA positive cases were 39 (97.5%) and 26 
(65%) respectively and both antibodies were present in 25 (62.5%) cases. IgG and 
IgA positive cases were 50 (96.15%) and 32 (61.54%) respectively and both 
antibodies were present in 31 (59.62%) cases out of 52 RUT negative patients. Of 40 
XIII 
 
RUT positive cases, 39 (97.5%) were stool Ag positive. Among 52 RUT negative 
cases, 19 (36.53%) were positive for stool Ag. Among 58 stool Ag positive patients, 
57 (98.27%) cases were IgG positive and 39 (67.24%) cases were IgA positive and 38 
(65.52%) cases were positive for both antibodies. Out of 34 stool Ag negative cases, 
32 (94.11%) and 19 (55.88%) cases were positive for IgG and IgA respectively and 
both antibodies were present in 19 (55.88%) cases. Among 31 infants stool samples 
examined for H. pylori antigen as control, 30 (96.77%) were negative for stool Ag. In 
58 stool Ag positive cases, serum IgG and IgA mean titre were (2.09 ± 0.46) and 
(1.40 ± 1.01) respectively. IgG mean titre was 1.94 ± 0.52 and IgA mean tire was 1.23 
± 0.95 in 34 stoo Ag negative patients. H. pylori stool antigen assay (HpSA) gave the 
highest rate of detection (63.04%), followed by serum antibody detection (61.96 %) 
and the lowest by RUT (43.48%).  
H. pylori stool antigen assay (HpSA) could be used as a routine diagnostic tool for H. 
pylori infection.  
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INTRODUCTION 
Helicobacter pylori formerly known as Campylobacter pyloridis then Campylobacter pylori, 
is one of the human pathogens with highest prevalence around the world (Parsonnet et al., 
1999). It is a small, spiral-shaped, gram-negative, multi-flagellated, micro-aerophilic bacteria 
commonly found in the gastric mucosa lining the upper gastrointestinal tract (stomach and 
duodenum) of humans and animals. 
Helicobacter pylori infection is ubiquitous and infects both males and females (Goh, 1997; 
Newell, 1987). More than half of the world's population is infected with H. pylori, which is 
acquired almost always within the first 5 years of life (Suerbaum and Michetti, 2002). The 
prevalence of H. pylori infection varies widely by geographic area, age, race, ethnicity, and 
socioeconomic status (Feldman, 2001). The overall prevalence of H. pylori infection is 
strongly correlated with socioeconomic conditions. Rates appear to be higher in developing 
than in developed countries, with most of the infections occurring during childhood, and they 
seem to be decreasing with improvements in hygiene practices (Malaty and Graham, 1994). 
Epidemiological data from developed and developing countries suggest that the prevalence of 
H. pylori infection in children under 10 years resident in developed countries being 
approximately 0 to 5% compared with 13 to 60% in children resident in developing countries. 
Over this age an increase in prevalence in the order of 0.5 to 2% per annum is commonly 
observed (Al-Moagel et al., 1990; Graham et al., 1991; Jones et al., 1986). The prevalence 
among middle-aged adults is over 80 percent in many developing countries, as compared 
with 20 to 50 percent in industrialized countries (Rowland et al., 1999).  
Like other developing countries, the prevalence of H. pylori is very high in Bangladesh. The 
reported prevalence of H. pylori infection in adults is about 90% (Bhuiyan, 2010) and more 
than 80% children become infected with H. pylori by the age of 6-9 years (Mahalanabis et 
al.,1996 ) and  92% adult population are seropositive for H. pylori in Bangladesh (Ahmad et 
al., 1997). 
Helicobacter pylori has become the major pathologic agent in the development of chronic 
gastritis (Dooley et al., 1989; Flocca et al., 1987), gastric ulcer, duodenal ulcer, MALT 
lymphoma and gastric cancer and non-ulcerative dyspepsia (Elta et al., 1991) in human. The 
International Agency for Research on Cancer (IARC) has classified H. pylori as a class 1 
carcinogen which is in the same class as cigarette smoke (Goodwin and Worsley, 1993; 
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Atherton, 1997; Marshall et al., 1990). It may also be a risk factor for pancreatic cancer 
(Trikudanathan et. al, 2011). Association of H. pylori has also been demonstrated with some 
extra-gastric diseases including several autoimmune diseases (Elseweidy, 2013).  H. pylori 
infection can lead to impaired glucose tolerance (Chen and Blaser, 2012; Jeon et al., 2012). 
Recent data from NHANES found a significant association between H. pylori infection and 
increased A1c levels (Chen and Blaser, 2012). In another study, elderly Latinos with H. 
pylori infection were nearly 3 times more likely to develop diabetes than non-infected 
individuals (Jeon et al., 2012).  In a community based endoscopic survey among adult 
population, the prevalence of peptic ulcer disease was found to be 15.6% ((Hasan et al., 
1987), duodenal ulcer to be 11.9% above the age of 15 years (Enroth et al., 2000) in 
Bangladesh. 
This association between H. pylori and gastroduodenal diseases necessitates the proper and 
timely diagnosis of H. pylori infection in dyspeptic patients. Both invasive and non-invasive 
tests are available for diagnosis. The choice of test depends on the cost (variable in each 
country), availability, clinical situation, prevalence of infection, pretest probability of 
infection, and presence of confounding factors (e.g. the use of proton pump inhibitors and 
antibiotics) that may influence test results. 
 
Invasive tests which require endoscopy for diagnostic or therapeutic evaluation. Invasive tests 
available in clinical practice include: gastric biopsies for culture, gram stain, histology or 
rapid urease test (RUT). 
 
H. pylori culture is the gold standard for diagnosis of H. pylori infection but generally it is 
not available in most laboratories because it requires special growth condition and of being 
fastidious organism. 
 
Histopathological examination can provide important information about morphological 
features indicating severity of gastritis and evidence for dysplasia. However, the accuracy of 
histopathological examination may be variable due to density of H. pylori and sampling error. 
The accuracy of this test can be improved by adequate biopsies from the antrum and body of 
the stomach and by special staining such as a silver staining and the Diff-Quik stain (El-
Zimaity et al., 1998).  Although histopathology and culture of the organism, which are not 
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easily and routinely performed, is considered the gold standard for the diagnosis of H. pylori 
infection, we need rapid, accurate and reliable noninvasive methods (Kabir, 2001). 
 
The rapid urease test (RUT) is simple and provides quick results (Granstrom et al., 2008). 
The presence of urease that is produced by H. pylori results in hyhdrolysis of neutral urea to 
alkaline ammonia, which is then visualized by a change in color of the pH indicator. The 
RUT has a high sensitivity (95%) and specificity (95%) (Howden and Hunt, 1998), making it 
an excellent primary diagnostic test. 
Any concomitant use of antibiotics however will reduces bacterial load, and may lead to false 
negative results in rapid urease tests (RUT), urea breath test and histology (Vilaichone et al., 
2006).  Furthermore, the presence of other microorganisms that produce urease can lead to 
false-positive results (Mégraud and Lehours, 2007). 
 
The noninvasive tests available in clinical practice include serologic tests, urea breath tests 
(UBT), and stool antigen tests (HpSA). 
Serology is widely used for screening patients for H. pylori infection. It has a good 
sensitivity, it is fast, and relatively inexpensive, but it cannot be used after H. pylori treatment 
(Vaira et al., 2000). The serological tests are simple and cheap. IgM antibody test has not 
proven to be useful clinically, whereas anti–H. pylori IgG and IgA have a better result. Anti–
H. pylori IgG usually can be detected by 3-4 weeks after infection. 
Most serologic tests carries a high sensitivity (~90 to 100%), but variable specificity (under 
85-90%). Their positive and negative predicative values depend upon the background 
prevalence of H. pylori infection in the population at risk. In areas where infection is 
common, a negative result is likely to be a false negative. Conversely, a positive result 
amongst those in whom H. pylori is infrequent is more likely to be a false positive. In 
developed countries with low prevalence of H. pylori infection, a positive serological test 
signals active infection only about half the time. Hence, serology should be validated locally. 
Further, antibody tests can remain positive for years after H. pylori eradication and have 
limited value to confirm H. pylori infection.  
The UBT provides a reliable noninvasive method for detection of H. pylori infection with 
sensitivity and specificity of 88-95% and 95%-100% respectively (Howden and Hunt, 1998). 
Urea breath test is not only sensitive and specific but also has an important advantage to 
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confirm H. pylori eradication. Following ingestion of 13C- or 14C-urea, H. pylori-produced 
urease enzyme that is resident in the stomach hydrolyzes this labeled urea to 14CO2 or 13CO2, 
which can be detected in breath samples (Vaira et al., 1999). The nonradioactive13C (a stable 
label) test and the radioactive 14C test have received US Food and Drug Administration 
(FDA) approval for H. pylori diagnosis. The dose of radiation in the 14C-urea test however is 
not approved for use in children and pregnant women (Vilaichone et al., 2006). Moreover, 
the UBT requires an expensive instrument such as a mass spectrometer, which is not always 
available in routine clinical laboratories (Hoda et al., 2006).  
As a gastrointestinal pathogen, H. pylori also appear in the stool. It allows the development of 
fecal assays like H. pylori culture, DNA detected by polymerase chain reaction (PCR), or H. 
pylori stool antigen (HpSA) testing. Among them only stool antigen has proven to be 
clinically useful with sensitivities and specificities of more than 90%. Stool antigen assay is 
advantageous to confirm eradication (Vilaichone et al., 2006). It can be used as a routine 
diagnostic tool for H. pylori infection because it seems to overcome the limitations of the 
conventional invasive techniques. This new immune-chromatographic test (ICT) has the 
advantage of being non invasive, easy and fast to perform, useful with individuals for whom 
endoscopy is difficult to justify, to monitor treatment response and cheaper than the invasive 
and molecular tests. Moreover, HpSA indicates the active infection of the patient with H. 
pylori. 
The aim of the present study was to evaluate the efficacy of H. pylori stool antigen detection 
test (HpSA) to diagnose H. pylori infection in dyspeptic patients in comparison with 
traditional techniques.  
Objectives:  
The Objectives of the present study were to:  
 do rapid usease test using antral biopsy material of the dyspeptic patients obtained 
during upper GIT endoscopy. 
 determine anti- H. pylori IgA and IgG level in dyspeptic patients. 
 detect H. pylori antigen from stool samples of the patients. 
 detect H. pylori antigen from stool samples of the neonates taken as control.  
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REVIEW OF LITERATURE 
Overview 
Today's understanding of Helicobacter-related gastric diseases in humans stems from an 
explosion in research, which occurred after the first culture of the organism by Marshall and 
Warren in 1982 (Warren and Marshall, 1983). This event may have been the culmination of 
over 100 years of study of helicobacters and their epiphenomena. The presence of spiral-
shaped micro-organisms in stomach mucosa was described almost 100 years ago (Madan et 
al., 1988). This discovery rapidly revolutionized the discipline of gastroenterology in human 
medicine and identified it as the causative agent of gastritis and peptic ulcer (Warren and 
Marshall, 1984). 
History 
By the late 19th and early 20th centuries, several investigators had reported the presence of 
spiral microorganisms in the stomachs of animals (Bizzozero, 1893). Soon afterward, similar 
spiral bacteria were observed in humans (Krienitz, 1906; Luger, 1917), some of whom had 
peptic ulcer disease or gastric cancer. The etiological role of these bacteria in the 
development of peptic ulcer disease and gastric cancer was considered at that time, and 
patients were sometimes even treated with high doses of the antimicrobial compound bismuth 
(Pel, 1899). This possibility was later discarded as irrelevant, probably because of the high 
prevalence of these spiral bacteria in the stomachs of persons without any clinical signs. The 
bacteria observed in human stomachs were thus considered to be bacterial overgrowth or 
food contaminants until the early 1980s. At that time, Warren and Marshall performed their 
groundbreaking experiments, leading to the identification of a bacterium in 58 of 100 
consecutive patients, with successful culture and later demonstration of eradication of the 
infection with bismuth and either amoxicillin or tinidazole (Marshall et al., 1985). The 
organism was initially named “Campylobacter-like organism,” “gastric Campylobacter-like 
organism,” “Campylobacter pyloridis,” and “Campylobacter pylori” but is now named 
Helicobacter pylori in recognition of the fact that this organism is distinct from members of 
the genus Campylobacter (Goodwin et al., 1989). It soon became clear that this bacterium 
causes chronic active gastritis, which in a subset of subjects may progress to other conditions, 
in particular, peptic ulcer disease, distal gastric adenocarcinomas and gastric lymphomas 
(Ernst and Gold, 2000).   
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Microbiology 
Genus Description and Phylogeny 
The genus Helicobacter belongs to the subdivision of the Proteobacteria, order 
Campylobacterales, family Helicobacteraceae. This family also includes the genera 
Wolinella, Flexispira, Sulfurimonas, Thiomicrospira, and Thiovulum. To date, the genus 
Helicobacter consists of over 20 recognized species, with many species awaiting formal 
recognition (Fox, 2002). Members of the genus Helicobacter are all microaerophilic 
organisms and in most cases are catalase and oxidase positive, and many but not all species 
are also urease positive. 
 
Helicobacter species can be subdivided into two major lineages, the gastric Helicobacter 
species and the enterohepatic (nongastric) Helicobacter species. Both groups demonstrate a 
high level of organ specificity, such that gastric helicobacters in general are unable to 
colonize the intestine or liver, and vice versa. An extensive review of non-pylori 
Helicobacter species is available (Solnick and Schauer, 2001), and here we briefly discuss 
those Helicobacter species that are either associated with human disease or have relevance 
for animal models of human Helicobacter infections (Table 2.1). 
Table 2.1: Characteristics of selected Helicobacter species. 
Species Primary 
mammalian 
host 
Pathology Animal model 
Gastric Helicobacter spp. 
 H. pylori Human, primate Gastritis, peptic ulcer disease, 
gastric adenocarcinoma, 
MALT lymphoma 
 
Mouse, 
Mongolian 
gerbil, Guinea 
pig, 
Gnotobiotic 
piglet 
H. felis 
 
Cat, dog, mouse 
 
Gastritis in natural host; may 
cause peptic ulcers or gastric 
adenocarcinoma in mouse 
Mouse 
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H. mustelae Ferret Gastritis, peptic ulcer disease, 
gastric adenocarcinoma, 
MALT lymphoma 
None 
H. acinonychis Cheetah, tiger, 
other big cats 
Gastritis, peptic ulcer disease Mouse 
H. heilmannii Human, dog, 
cat, monkey, 
cheetah, rat 
Gastritis, dyspeptic symptoms, 
MALT lymphoma 
Mouse 
Enterohepatic Helicobacter spp. 
H. hepaticus Mouse, other 
rodents 
Proliferative typhlocolitis, 
hepatitis, hepatocellular 
carcinoma 
None 
 
Microbiological characteristics of H. pylori 
Helicobacter pylori (H. pylori) is a slow-growing, microaerophilic, spiral shaped multi 
flagellated, gram-negative bacterium, about 3 micrometres long with a diameter of about 0.5 
micrometres, whose surface is coated with 12–15 nm ring-shaped aggregates of urease and 
heat shock protein. The urease enzyme and the heat shock protein B are located almost 
exclusively within the cytoplasm in the fresh log-phase cultures of H. pylori. In subcultures, 
urease and heat shock protein B become associated with the bacterial surface, suggesting 
bacterial autolysis leading to release of protein and adsorption into the bacterial surface. 
Some of the lipopolysaccharide of the organism mimics the Lewis blood group antigens in 
structure. This molecular mimicry also helps in the continued existence of H. pylori in the 
unfavorable gastric environment. This bacterium colonizes gastric mucosa and elicits both 
inflammatory and immune lifelong responses, with release of various bacterial and host-
dependent cytotoxic substances (Peterson et al., 1998).  Under unfavorable circumstances it 
can become coccoidal, a nonculturable form with debatable viability. The bacterium is a 
microaerophilic and capnophilic organism, slowly growing with rigorous culture demands 
(Mégraud and Lehours, 2007). 
 
 
Evaluation of Helicobacter pylori stool antigen detection test  
 
Figure 2.1: Components of Helicobacter pylori with biological activity 
 
Genome structure 
H. pylori consist of a large diversity of strains, and the genomes of three have been 
completely sequenced (Tomb et al., 1997; Oh et al., 2006). The genome of the strain "26695" 
consists of about 1.7 million base pairs, with some 1,550 genes. The two sequenced strains 
show large genetic differences, with up to 6% of the nucleotides differing ("Helicobacter 
pylori26695, complete genome, 2008).  
Study of the H. pylori genome is centered on attempts to understand pathogenesis, the ability 
of this organism to cause disease. Approximately 29% of the loci are in the "pathogenesis" 
category of the genome database. Two of sequenced strains have an approximately 40 kb-
long Cag pathogenicity island (a common gene sequence believed responsible for 
pathogenesis) that contains over 40 genes. This pathogenicity island is usually absent from H. 
pylori strains isolated from humans who are carriers of H. pylori, but remain asymptomatic 
(Baldwin et al., 2007).  
The cagA gene codes for one of the major H. pylori virulence proteins. Bacterial strains that 
have the cagA gene are associated with an ability to cause ulcers (Broutet et al., 2001). The 
cagA gene codes for a relatively long (1186 amino acid) protein. The cag pathogenicity 
island (PAI) has about 30 genes, part of which code for a complex type IV secretion system. 
The low GC-content of the cag PAI relative to the rest of the Helicobacter genome suggests 
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the island was acquired by horizontal transfer from another bacterial species (Tomb et al., 
1997). 
Cell Biology of H. pylori 
Factors involved in colonization and adhesion 
Several virulence factors for gastric colonization, tissue damage, and survival have been 
identified in H. pylori (Table 2.2). Flagella, urease, and adhesins are all essential factors for 
H. pylori to colonize the gastric mucosa. Mutants of H. pylori without flagella or without 
urease are unable to colonize the gastric mucosa in laboratory animals (Eaton et al., 1991). 
Table 2.2: Virulence factors identified in H. pylori 
Virulence factor Effect 
Colonizing 
Flagella Active movements through mucin 
Urease Neutralization of acid 
Adhesins Anchoring H. pylori to epithelium 
Tissue damaging 
Proteolytic enzymes Glucosulfatase degrades mucin 
120-kDa cytotoxin (Gac A) Related to ulcer and severe gastritis 
Vacuolating cytotoxin (Vac A) Damage of the epithelium 
Urease Toxic effect on epithelial cells, disrupting 
cell tight junctions 
Phospholipase A Digest phospholipids in cell membranes 
Alcohol dehydrogenase Gastric mucosal injury 
Survival 
Intracellular surveillance Prevent killing in phagocytes 
Superoxide dismutase Prevent phagocytosis and killing 
Catalase Prevent phagocytosis and killing 
Coccoid forms Dormant form 
Heat Shock proteins 
Urease Sheathing antigen 
Others 
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Lipopolysaccharide Low biological activity 
Lewis X/Y blood group homology Autoimmunity 
                                                 Source: Chapter 4, Basic Bacteriology and Culture 
 
Flagella and motility 
The curved morphology of H. pylori and the polar motility caused by flagella in one end 
cause screw-like movements, which may enable the organism to penetrate the mucin layer. 
The motility of H. pylori is increased when the viscosity of the media is increased in vitro and 
transverses a methyl glucose solution 10 times more efficiently than Escherichia coli (Hazell 
et al., 1986), but the motility is pH dependent and impaired at a pH below 4 (Miller-Podraza 
et al., 1999). 
 
Urease, catalase, superoxide dismutase, and alkylhydroperoxidase reductase 
Urease is one of the key enzymes in H. pylori pathogenesis. It has a molecular weight of 550 
kDa and consists of three subunits of 26.5 kDa (Ure A), 61 kDa (Ure B), and 13 kDa (Ure C) 
(Labigne et al., 1991; Mobley et al., 1988). Urease is necessary for H. pylori to maintain a 
pH-neutral microenvironment around the bacteria, necessary for survival in the acidic 
stomach (Hawtin et al., 1990; Perez-Perez et al., 1992). Urease induces self-destruction of H. 
pylori in vitro in nonacidic media (Neithercut et al., 1991). Urease is strongly immunogenic 
and chemotaxic for phagocytes. 
Superoxide dismutase has been isolated from H. pylori, which breaks down superoxide 
produced in polymorphonuclear leukocytes and macrophages and thereby prevents the killing 
of these organisms (Spigelhalder et al., 1993). Catalase protects H. pylori against the 
damaging effects of hydrogen peroxide released from phagocytes (Hazell et al., 1991). 
Urease and catalase may be excreted from H. pylori to the surrounding environment and may 
protect this pathogen from the humoral immune response (Hawtin et al., 1990). 
 
Outer membrane proteins, phospholipids, glycolipids, and other adhesins 
H. pylori adheres to mucin and binds specifically to gastric mucosa epithelial cells both in 
vivo and in vitro (Hessay et al., 1990; Falk et al., 1993; Tzouvelekis et al., 1991). Different 
adhesion patterns, which are different in children and in adults, have been described (Blom et 
al., 2000). Several putative gastric tissue receptor structures have been described for H. pylori 
such as (i) sialoglycoconjugates in gastric mucins and on epithelial cells, phagocytes, and 
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extra-cellular matrix ( Evans et al., 1988; Hynes  et al., 1999; Wadstrom  et al., 1996), (ii) 
sulfated glycoconjugates such as heparan sulfate and other glycosaminoglycans (Wadström et 
al., 1999), and (iii) sulfatides (Saitoh et al., 1991; Utt and Wadström, 1997) and various 
sialylated and nonsialylated glycolipids (Miller-Podraza et al., 1999). 
 
Binding of H. pylori to cell surface fucosylated blood group antigens, H1 and Lewis part of 
the blood group O in the ABO system, was first described by Borén and collaborators (Borén 
et al., 1993) and was shown to mediate adherence to human and rhesus monkey gastric tissue 
surface cells (Borén et al., 1997). More recently, Peterson and collaborators (Peterson et al., 
2000) identified the H. pylori blood group antigen-binding adhesins, Bab A and Bab B, 
purified the proteins, and cloned the babA and babB genes. Two closely related basic proteins 
of 78 kDa were characterized. The sialic acid-specific lectins of 19 and 23 kDa have also 
been purified and the corresponding genes cloned (T. Borén, personal communication). These 
proteins, unlike BabA and -B, do not belong to the family of proteins, mostly named 
helicobacter outer membrane proteins by a nomenclature introduced by T. J. Trust and 
associates. Cell surface adhesins recognizing sulfatides were not identified, whereas heparan 
sulfate binding proteins (HeBPs) were purified and characterized by Utt et al. (151; 
unpublished). None of the glycolipid-binding surface proteins has been purified and 
characterized yet. Interestingly, no similar putative mucin and cell adhesin has been identified 
in H. felis or other newly identified species, except for H. mustelae (P. O'Toole and T. Trust, 
personal communication). In vitro affinity binding studies for the Lewis binding give high-
affinity constants (Ka, − 2.5; 10 to 11 M) and also reveal high affinity for human mucin-
binding glycoconjugates to hemagglutinating sialic acid-specific adhesins or lectins (SALs) 
(Wadstrom et al., 1996). Recent studies by Syder et al. (Syder et al., 1999) in a transgene 
mouse model suggest that SALs may become key adhesins in inflamed gastric mucosa. It is 
noteworthy that these SALs are produced already in the exponential growth phase while the 
Bab A and B adhesins appear mainly in the stationary phase cells. SALs and HeBPs may be 
the key receptors on leukocytes and macrophageys, and trigger lectinophagocytosis as for 
several other microbial pathogens (Wadstrom et al., 1999). 
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Factors involved in tissue damage and survival factors  
Enzymes: protease, etc 
Conflicting results have been reported concerning proteolytic enzymes in H. pylori. It seems 
probable that H. pylori glycosulfatase degrades gastric mucin (Sidebotham et al., 1991; 
Slomiany et al., 1992). H. pylori possess phospholipase A, which can digest phospholipids of 
cell membranes (Langton and Cesareo, 1992). Urease has a cytotoxic activity (Minocha et 
al., 1994). Recently, alcohol dehydrogenase has been described to contribute to gastric 
mucosal injury (Roine et al., 1992). 
Toxins: vacuolating cytotoxin A, lipopolysaccharide 
Helicobacter pylori contains a toxin, Vac A, which can produce vacuoles in gastric epithelial 
cells and has been related to peptic ulcer, severe gastritis (Catrenich and Chestnut, 1992; 
Cover et al., 1993), and mucosal integrity (Figura, 1996). Lipopolysaccharide (LPS) in H. 
pylori has a low biological activity as compared to LPS from other gram-negative bacteria 
(Nielsen, 1994), which may be explained by the unusual composition of lipid A (Mattsby-
Baitzer et al., 1992). LPS from H. pylori stimulates phenotypic transcription and functional 
changes in monocytes (Nielsen, 1994). Assays using gastric mucosal laminin (integrin) 
receptor binding to a laminin-coated surface have revealed a significant decrease in receptor 
binding occurring in the presence of H. pylori LPS. When the gastric epithelial barrier is 
weakened by disruption of the mucosal surface cells and the extracellular matrix, LPS is 
responsible for a marked increase in epithelial cell apoptosis (Piotrowski et al., 1997). LPS 
from H. pylori has recently attracted interest because LPS from most strains mimic Lewis 
and/or Lewis blood group antigens (Moran et al., 1996). This mimicry may play a role in the 
regulation of the immune response and induce autoantibodies against the gastric proton 
pump. 
Other putative virulence factors 
Several heat shock proteins (Hsp) such as 58.2-kDa Gro-El (Hsp B), 13-kDa Gro-Es (Hsp A), 
and a 70-kDa Hsp have been identified in H. pylori (Moutiala et al., 1992; Dunn et al., 1992). 
Hsp are produced by all cells and are involved in stabilizing and probably repairing proteins 
under harsh conditions that may be important to survive in the stomach. 
Helicobacter pylori transforms into coccoid forms (Bode et al., 1992; Catrenich and Makin, 
1991) under certain conditions such as nutrient starvation and media containing growth 
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inhibitors (bismuth, proton pump inhibitor, or certain antibiotics). These coccoid forms have 
been reported to survive for several years in river water and have been proposed by some to 
be an important factor for transmission, by fecal excretion, and for therapy failure. 
Figure 2.2:  Helicobacter pylori virulence factors in gastritis and gastric cancer 
 
Epidemiology 
Helicobacter pylori is now regarded as the most widespread infection in man: it has a world-
wide distribution and it is estimated that approximately two-thirds of the entire world’s 
population is infected with this pathogen (Dunn et al., 1990). Most infections are believed to 
be acquired during childhood and appear to persist for decades (Blaser, 1996). H. pylori is 
known to be the most important causal agent of human gastritis, gastric and duodenal ulcers, 
and has recently been classified as a first class human carcinogen by IARC (International 
Agency for Research on Cancer) (Anonymous, 1994). 
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Figure 2.3: Global prevalence of H. pylori infection. 
 
The prevalence of H. pylori shows large geographical variations and may differ between 
different ethnic, social, or age groups within the same country [Malaty, 1996; Goh, 1997; 
Mitchell, 1992). Globally, the prevalence of H. pylori infection in developing countries is 
markedly higher than that in developed countries (Mégraud et al., 1989; Graham et al., 1991; 
Bardhan, 1997; Perez-Perez et al., 2004). Moreover, the acquisition of H. pylori seems to 
occur at higher rates in developing countries (Pounder, 1995; Mitchell et al., 1992). In 
various developing countries, more than 80% of the population is H. pylori positive, even at 
young ages (Perez-Perez et al., 2004). The prevalence of H. pylori in industrialized countries 
generally remains under 40% and is considerably lower in children and adolescents than in 
adults and elderly people (pounder, 1995). Within geographical areas, the prevalence of H. 
pylori inversely correlates with socioeconomic status, in particular in relation to living 
conditions during childhood (Malaty, 1996). In Western countries, the prevalence of this 
bacterium is often considerably higher among first- and second-generation immigrants from 
the developing world (Perez-Perez et al., 2005; Tsai et al., 2005). While the prevalence of H. 
pylori infection in developing countries remains relatively constant, it is rapidly declining in 
the industrialized world (Genta, 2002). The latter is thought to be caused by the reduced 
chances of childhood infection due to improved hygiene and sanitation and the active 
elimination of carrier ship via antimicrobial treatment. In developing countries, H. pylori 
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infection rates rise rapidly in the first 5 years of life and remain constantly high thereafter, 
indicating that H. pylori is acquired early in childhood (Feidorek et al., 1991). However, in 
industrialized countries the prevalence of H. pylori infection is low early in childhood and 
slowly rises with increasing age. This increase results only to a small extent from H. pylori 
acquisition at later age. The incidence of new H. pylori infections among adults in the 
Western world is less than 0.5% per year; the higher prevalence of infection among the 
elderly thus reflects a birth cohort effect with higher infection rates in the past (Kuipers et al., 
1995; Parsonnet, 1995). The active elimination of H. pylori from the population and 
improved hygiene and housing conditions have resulted in a lower infection rate in children, 
which is reflected in the age distribution of this lifelong-colonizing bacterium ( Rehnberg et 
al., 2001; Kuipers, 1999). Overall, new infection more commonly occurs in childhood and 
lasts for life unless specifically treated. A plethora of studies reported and emphasized these 
differences within and between countries (Table 2.3). 
Table 2.3: Prevalence of H. pylori infection in different populations of the world 
Country Number 
of  
Studies 
Age range  
(Years) 
Prevalence 
(%) 
Reference 
Developing countries1 
Bangladesh 181 20-44 92% Ahmad et al., 1997 
Brazil  
8u-Rural 40(Children) <20 77.5% Souto et al., 1998 
164(Adults) 20-90 84.7% 
-Urban 363 >20 63.4% Santos et al., 2005 
-Poor urban 
community  
204 18-80 80% Rodrigues et al., 2005 
Colombia(rural) 684 2-9 69% Goodman et al., 1996 
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China  
-South China 1727 N/A 44.2% Mitchell et al., 1992 
-Hong Kong 397 36-65 58.6% Wong et al., 1999 
Changle of Fujan 1456         -       80.4% Wong et al., 1999 
Egypt  
Alexandria 
(northern) 
169 mothers N/A 88% Bassily et al., 1999 
 169 children < 1 13% 
  1.5 25% 
- Cairo (central) 52 < 6 33% Frenck et al., 2005 
56 > 6 60% 
-Assiut (southern) Urban N/A 87% Sayed et al., 2007 
Rural N/A 40% 
- poor urban area Schoolchildren N/A 72.4% Mohammad et al., 2008 
India 238 3-70 79% Graham et al., 1991 
Mexico 11605 20-90 66% Torres et al., 1998 
Nepal (rural)  1142 4-93 56.8% Kawasaki et al., 1998 
407 2 mo-12 yr 48% Klein et al., 1991 
Peru 104 0-17 50% Begue et al., 1998 
Russia 213 20-75 88% Malaty et al., 1996 
- St. Petersburg 
1995 
307 2-19 44% Tkachenko et al., 2007; 
Mataly et al., 1996 
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- St. Petersburg 
2005 
370 2-19 13% Tkachenko et al., 2007 
Saudi Arabia 557 5-10 40% Al-moagel et al., 1990 
  > 20 70%  
Taiwan 823 1-40+ 54% Teh et al., 1994 
Developed Countries1: 
Australia (urban 
Melbourne)  
273 19-47 23% Lambert et al., 1995 
Denmark 3589 30-60 25.9% Andersen et al., 1996 
Germany 
(western)  
260 18-61 39.2% Breuer et al., 1996 
Israel (rural)  377 30-90 72% Gilboa et al.., 1995 
Japan 4361 19-69 30% Kikuchi et al., 1998 
Netherlands 254 (employees) 11-89 27.2% Böhmer et al., 1997 
New Zealand 579 workers: 40-64 56%  
- Europeans 190  35.8%  
- Maori 195  57.4%  
- Pacific Islanders 194  73.2% Fraser et al., 1996 
Spain 332 > 18 43% Senra-Varela et al., 1998 
- mountain 178                   54% 
- coastal 154  30% 
South Korea 161 20-75 75% Malaty et al., 1996 
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Switzerland 176 natives 10-20 7.3% Heuberger et al., 2003 
 20 immigrants  30% 
United Kingdom 
- England 267 (healthy) > 18 41% Harris et al., 1995 
 467 (all males) 18-65 37.5% Webb et al., 1996 
- Northern Ireland 4742 12-64 50.5% Murry et al., 1997 
- South Wales 1796 45-59 70% Strachan et al., 1998 
United States 
- South Carolina 938 army 
recruits 
17-26 26%  
324 blacks  44% Smoak et al., 1994 
47 Hispanics  38% 
536 whites  14% 
- California 556 20-39 27% Replogle et al., 1995 
- Texas 246 blacks 15-80 70% Graham et al., 1991 
239 whites 34%  
                                                                Source: Khalifa et al. Gut Pathogens 2010 2:2 
1. The classification into developing or developed countries was retrieved from the United 
Nation Development Programme's Human Development Reports (URL: 
http://hdr.undp.org/en webcite). 
N/A: Data not available or not applicable 
 
Transmission of H. pylori 
The mode of transmission of H. pylori is one of the most controversial areas in the study of 
this pathogen. The exact mechanisms whereby H. pylori is acquired are largely unknown.  
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H. pylori has a narrow host range and is found almost exclusively in human and some 
nonhuman primates. Despite hostile, the human stomach is the only identified reservoir for H. 
pylori. Although extensively studied, efforts to confirm the exact route of transmission have 
been disappointing. It has been speculated that the person-to-person spread currently 
appeared to be the most likely mode of transmission, especially between family members 
(Weyermann et al., 2006; Kivi et al., 2005). Hence, the possible routes are fecal–oral, oral–
oral and gastro–oral (Gold, 2001).Thomas et al., were able to isolate H. pylori DNA and 
culture H. pylori from human feces, suggesting a fecal–oral transmission (Thomas et al., 
1992). Oral–oral transmission has also been recognized because H. pylori was isolated from 
dental plaques and saliva (Theron et al., 2002). Furthermore, gastric–oral transmission was 
also suggested after the organism was cultured from vomitus (Siu et al., 1999; Parsonnet et 
al., 1999). This was further strengthened by Perry et al., who found that this transmission 
correlates with exposure to an infected family member with gastroenteritis, especially with 
vomiting (de la Luz Sanchez et al., 2006). Other possible ways of transmission include water-
borne transmission (Graham et al., 1991) and vector-borne transmission (Hoffman et al., 
1997; Grubel et al., 1998). Environmental or animal reservoirs were investigated as sources 
of H. pylori infection. Food, animals, and water sources have been suggested as reservoirs 
outside the human gastrointestinal tract, and H. pylori or its DNA was detected in each of 
these sources (Kurosawa et al., 2000).  Therefore, it is evident that the current knowledge on 
the exact modes of transmission is not optimal, and further studies are needed to clarify this 
clinically and epidemiologically important aspect of H. pylori. 
Pathogenesis of H. pylori infection 
The primary disorder, which occurs after colonization with H. pylori, is chronic active 
gastritis. This condition can be observed in all H. pylori-positive subjects. The intragastric 
distribution and severity of this chronic inflammatory process depend on a variety of factors, 
such as characteristics of the colonizing strain, host genetics and immune response, diet, and 
the level of acid production. H. pylori-induced ulcer disease, gastric cancer, and lymphoma 
are all complications of this chronic inflammation; ulcer disease and gastric cancer in 
particular occur in those individuals and at those sites with the most severe inflammation. 
Understanding of these factors is thus crucial for the recognition of the role of H. pylori in the 
etiology of upper gastrointestinal pathology. 
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The gastric mucosa is well protected against bacterial infections. H. pylori is highly adapted 
to this ecologic niche, with a unique array of features that permit entry into the mucus, 
swimming and spatial orientation in the mucus, attachment to epithelial cells, evasion of the 
immune response, and, as a result, persistent colonization and transmission. To colonize the 
stomach, H. pylori must survive the acidic pH of the lumen and use its flagella to burrow into 
the mucus to reach its niche, close to the stomach's epithelial cell layer (Amieva & El-Omar, 
2008). Many bacteria can be found deep in the mucus, which is continuously secreted by 
mucus-secreting cells and removed on the luminal side. To avoid being carried into the 
lumen, H. pylori senses the pH gradient within the mucus layer by chemotaxis and swims 
away from the acidic contents of the lumen towards the more neutral pH environment of the 
epithelial cell surface (Schreiber et al., 2004).  
Figure 2.4: Pathogenesis of H. pylori infection 
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To survive in the presence of acid produced in the stomach H. pylori has to counteract this 
acidic environment. H. pylori produce an important enzyme, urease, which hydrolyses urea 
into NH3 and CO2. This enzyme has an essential role in the H. pylori infection as observed in 
urease-defective bacteria mutants which cannot colonize the stomach (Montecucco and 
Rappuoli, 2001). Urease causes damage to the epithelium through the production of 
ammonia, that in conjunction with neutrophil metabolites (Megraud et al., 1992), form 
carcinogenic agents that might participate in the development of gastric malignances 
((Megraud et al., 1992), Suzuki et al., 1992). Ammonia is capable of causing different cell 
alterations, including swelling of intracellular acidic compartments, alterations of vesicular 
membrane transport, repression of protein synthesis and ATP production, and cell-cycle 
arrest (Montecucco and Rappuoli, 2001). Urease might also help to the recruitment of 
neutrophils and monocytes in the mucosa and to the production of pro-inflammatory 
cytokines (Harris et al., 1996).  
H. pylori LPS are essential components of the bacterial outer membrane that induces a low 
immunological response in contrary to other bacteria (Moran, 1995). However, despite the 
low immunological activity of LPS, H. pylori colonization is associated with an inflammatory 
response, because H. pylori has the ability of activate mononuclear cells by LPS-independent 
mechanisms as well as other bacterial surface molecules (Moran, 1998). Another important 
component of the cell wall of H. pylori, peptidoglycan, interacts with the intracellular pattern 
recognition receptor Nod1 (an intracellular sensor for peptidoglycan from Gram-negative 
bacteria), this interaction leads to activation of NF-κB signaling, with the subsequent 
secretion of the inflammatory molecules IL-8 (Viala et al., 2004) and β-defensin-2 (Boughan 
et al., 2006). On the other hand, peptidoglycan translocation of H. pylori, leads to enhanced 
PI3K-AKT signaling, which mediates protection from apoptosis and cell migration, both 
phenotypes related to carcinogenesis (Nagy et al., 2009). 
Approximately 4% of the H. pylori genome is predicted to encode outer membrane proteins 
(OMPs) many of which serve as adhesins (Wroblewski et al., 2010), epithelial adhesion 
provides to H. pylori better access to epithelial surface and in this way contributes to deliver 
bacterial toxins such as CagA (Yamaoka, 2010). Fucosylated ABO blood group antigens and 
sialyl-Lewisx and sialyl-Lewisa antigens (sLex and sLea) have been identified as functional 
receptors for H. pylori (Boren et al., 1993). 
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The outer membrane inflammatory protein (OipA), identified in 2000 (Yamaoka et al., 2000), 
is involved in the attachment of H. pylori to gastric epithelial cells in vitro (Yamaoka, 2010). 
OipA is also involved in up-regulation of matrix metalloproteinase 1 (MMP-1), in inhibition 
of glycogen synthase kinase 3β (GSK-3β) and in β-catenin translocation to the nucleus, this 
protein also induces an inflammatory response and actin rearrangement through 
phosphorylation signaling pathways (Wroblewski et al., 2010), although, most of these are 
also involved in cag-PAI signaling alterations, suggesting that there might be some 
interaction between OipA and cag-PAI, it is important to note that it has been found a 
correlation coefficient of 0.82 between the oipA and cagA positivity in some virulent strains 
(Yamaoka et al., 2002).  
Blood group antigen binding adhesin (BabA) has been thought to be the primary protein 
involved in adherence to the gastric mucosa (Boren et al., 1993). It is encoded by the babA2 
gene (the babA1 although is present, is silent because of lack of an initiation codon (Mobley 
et al., 2001) and binds to fucosylated Lewisb antigen. Some studies report that the presence of 
babA2 is associated with duodenal ulcer and gastric cancer and found in conjunction with 
cagA and vacA s1 allele, provides a greater risk of develop a severe gastric disease (Gerhard 
et al., 1999). 
Sialic acid-binding adhesin (SabA) is responsible of H. pylori binding to syalylated Lex and 
Lea in epithelial cells. Infiltration of neutrophils into the gastric mucosa is a characteristic 
feature of chronic gastritis caused by H. pylori and SabA binds to neutrophils through these 
sialylated carbohydrates and induces oxidative burst in these cells, which has a consequence 
of produce oxidative damage in gastric epithelium. It has been proposed that SabA-positive 
status is associated with gastric cancer, intestinal metaplasia, and corpus atrophy and 
negatively associated with duodenal ulcer and neutrophil infiltration (Yamaoka, 2008). 
VacA is a pore-forming cytotoxin identified in supernatants of H. pylori broth cultures that 
cause aberrant vacuolation of cultured cells. This cytotoxin is secreted from the bacteria as a 
large 140-kilodalton polypeptide and latter trimmed at both ends to finally deliver it in an 
active form to host cells, where it exerts its activity.  
VacA induces multiple cellular activities, the best studied is the alteration on endosomal 
maturation which consequently leads to vacuolation of epithelial cells, VacA is also capable 
of induce membrane-channel formation, cytochrome c release from mitochondria, and 
binding to cell-membrane receptors activating a proinflammatory response (Amieva & El-
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Omar, 2008). VacA has the ability to cause leakage of ions and small molecules, by 
disrupting the barrier function of tight junctions and also inhibit T-cell activation and 
proliferation (Gebert et al., 2003). 
All strains of H. pylori contain the vacA gene, although, there is considerable genetic 
diversity among them, and consequently the cytotoxicity activity of the toxin varies between 
strains (Amieva & El-Omar, 2008). The diversity observed is attributed to variations in vacA 
gene structure within the signal (s) region, the middle (m) region, and the intermediate (i) 
region (Wroblewski et al., 2010). 
The amino terminus contains the signal sequence that shows allelic variability and has been 
classified into different types. Strains with s1 allele secrete an active toxin and are also highly 
associated with ulcers and gastric cancer (Atherton et al., 1995), however, s1/s2 combination 
or s2 genotypes are found in patients with gastric cancer (Lopez-Vidal et al., 2008). The 
middle region of the gene also shows allelic variation, with m1 subtype having stronger 
vacuolating activity and it is associated with an increased risk for development of gastric 
epithelial injury and gastric cancer (Yamaoka, 2010). The clinical isolates of H. pylori have 
been grouped into two broad families defined as type I and type II on the basis of whether 
they have a functional pathogenicity island (cag-PAI), and secrete an active vacuolating 
cytotoxin (VacA). Type I strains are positive for all these characteristics. In contrast, type II 
strains do not have a functional cag-PAI and possess the vacA gene that encodes for non-
toxic protein (Censini et al., 1996, Tomb et al., 1997). 
Colonization of the human stomach by H. pylori virulent strains is associated with a 
significantly increased risk for the development of several gastric diseases, such as gastric 
cancer. These highly virulent H. pylori strains harbor a (cytotoxin-associated genes) 
pathogenicity island (cag-PAI) that encode proteins that are components of a type IV 
secretion system (T4SS) apparatus and the CagA effector protein into host target cells 
(Castillo-Rojas et al., 2004). T4SS translocates the bacterial oncoprotein CagA and 
peptidoglycan that induces pro-inflammatory chemokine and cytokine secretion, including 
interleukin-8 (IL-8) in gastric epithelial cells (Figueiredo et al., 2005). The hallmark of H. 
pylori virulent strains is the presence of cag-PAI that induce of gastric mucosal inflammation, 
which is a risk factor for developing severe gastric pathologies (Antonio-Rincon et al., 2011). 
The presence of flanking direct repeated sequences 605 (IS605) in the cag-PAI have been 
reported to cause rearrangements and partial or total deletions of it. This has generated H. 
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pylori strains with varying virulence, and consequently, the clinical outcome of the infection 
(Censini et al., 1996). A systematic mutagenesis study with isogenic mutants in each of the 
cag-PAI genes, reported that 14 genes out of 27 of cag-PAI are essential for CagA 
translocation and induction of IL-8 secretion in gastric epithelial cells (Aguilar et al., 2001). 
CagA protein is the only known effector protein translocated to the host cell by the T4SS 
(Backert et al., 2010). It was firstly described as a very immunogenic protein in humans 
infected with cytotoxin-producing strains (Covacci et al., 1993). After that, its association 
with gastric cancer and peptic ulcer was well established. Recent reports suggest that CagA is 
able to down regulate the vacuolation effects of VacA on host cells, and conversely, VacA is 
able to down regulate CagA activity (Oldani et al., 2009). Clinical isolates that contain the 
cag-PAI generally are babA, oipA and vacA s1 positive, Yamaoka proposes that these 
virulence factors may interact with each other with a certain biological significance; 
therefore, these factors interact synergistically with each other to induce gastric diseases 
(Yamaoka, 2010). 
CagA is encoded by the cagA gene, located at one end of the cag-PAI (Censini et al., 1996). 
One copy per genome is present in most of the strains whose genome has been sequenced but 
strains with two gene copies might exist, as revealed by the genome sequence of the 
Amerindian strains H. pylori Shi470 and V225d, although functionality of both copies in 
these strains is unknown ( Mane et al., 2010). It has been estimated that 60-95% of strains 
worldwide carry the cagA gene, which is different between geographic regions (Hatakeyama, 
2004). However, the complete cag-PAI is important for the translocation of this protein and 
the completeness of the island may impact on the association of CagA presence and the 
outcome of the disease. 
Other main feature of CagA protein is its high variable size, which range from 120-145 kDa 
(Covacci et al., 1993). This variation is due to the presence of polymorphism at the carboxy-
terminal region given by the presence of repeat sequences called EPIYA motifs, which are 
present in a copy number varying from one to seven (Xia et al., 2009). Four major types of 
EPIYA motifs (A, B, C, and D) have been described based on the specific amino acid 
sequence that flanks the Glu-Pro-Ile-Tyr-Ala motif at both sides (Hatakeyama, 2004). 
It has been proposed that EPIYA motifs of CagA act as ‘‘master keys’’ that can potentially be 
tyrosine-phosphorylated by host kinases and are capable to interact with a wide range of 
different host cell proteins (Backert et al., 2010). In the same way, the observation that the 
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EPIYA-region is unstructured and can adopt multiple conformations mimicking host 
substrates of kinase families, thus manipulating eukaryotic cellular biochemistry during 
infection, provides further support for this "master key" hypothesis (Nesic et al., 2010). 
In contrast to the polymorphic C-terminal EPIYA region of CagA, N-terminal region is well 
conserved among CagA proteins (Hatakeyama, 2011). The N-terminal CagA region is 
required for the membrane association of CagA in polarized epithelial cells (Bagnoli et al., 
2005) and is important for its translocation into host cells (Murata-Kamiya et al., 2010), the 
first 200 amino acids at the N-terminus of CagA form a membrane-binding domain in H. 
pylori, mediating proper translocation of the CagA protein via the T4SS (Steininger et al., 
2011). 
 
Clinical features  
Chronic H. pylori –associated gastritis per se is asymptomatic but the initial acquisition of the 
infection cause acute gastritis with hypochlorhydria which may cause abdominal pain, nausea 
and vomiting that resolve within a few days (Fischer et al., 2001). Uncomplicated peptic 
ulcers typically cause epigastric pain and less commonly, nausea, vomiting and weight loss, 
whereas some ulcers (particularly NSAID ulcers) are asymptomatic. The classically 
described pain of duodenal ulcer is felt as a growing or burning sensation, often with a 
relation to meals; occurring 1-3 hours after meals and /or at night and relieved by food. 
Gastric ulcer pain is instead often precipitated by food. However symptoms are actually very 
poorly discriminatory for ulceration site and even for whether or not an ulcer is present. 
Examination usually reveals epigastric tenderness but may be normal. 
 
H. pylori related pathological conditions 
Disease types 
Although gastric colonization with H. pylori induces histologic gastritis in all infected 
individuals, only a minority develop any apparent clinical signs of this colonization. It is 
estimated that H. pylori-positive patients have a 10 to 20% lifetime risk of developing ulcer 
disease and a 1 to 2% risk of developing distal gastric cancer (Ernst and Gold, 2000; kuipers 
et al., 1995). The risk of development of these disorders in the presence of H. pylori infection 
depends on a variety of bacterial, host, and environmental factors that mostly relate to the 
pattern and severity of gastritis (Figure 2.5). 
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Figure 2.5: Schematic representation of the factors contributing to gastric pathology 
and disease outcome in H. pylori
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Figure 2.6: Peptic ulcers 
 
Gastric ulcers mostly occur along the lesser curvature of the stomach, in particular, at the 
transition from corpus to antrum mucosa (Veldhuyzen van Zanten et al., 1999). Both gastric 
and duodenal ulcer diseases are strongly related to H. pylori infection. In initial reports from 
all over the world in the first decade after the discovery of H. pylori, approximately 95% of 
duodenal ulcers and 85% of gastric ulcers occurred in the presence of H. pylori infection 
(Kuiper et al., 1995). Several cohort studies estimated that the lifetime risk for ulcer disease 
in H. pylori-positive subjects is 3 to 10 times higher than in H. pylori-negative subjects 
(Nomura et al., 1994) and that 10 to 15% of H. pylori-positive subjects developed ulcer 
disease during long-term follow-up (Sipponen et al., 1990). 
Eradication of H. pylori dramatically changes the natural course of ulcer disease and almost 
completely prevents ulcer recurrence (Hentschell et al., 1993).  
Non-ulcer dyspepsia 
Non-ulcer or functional dyspepsia is defined as the presence of symptoms of upper 
gastrointestinal distress without any identifiable structural abnormality during diagnostic 
work-up, in particular including upper gastrointestinal endoscopy. Thirty (30%) to 60% of 
patients with functional dyspepsia carry H. pylori, but this prevalence is not much different 
from that in the unaffected population (Talley and Hunt, 1997). 
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Atrophic gastritis, intestinal metaplasia, and gastric cancer 
Chronic H. pylori-induced inflammation can eventually lead to loss of the normal gastric 
mucosal architecture, with destruction of gastric glands and replacement by fibrosis and 
intestinal-type epithelium. This process of atrophic gastritis and intestinal metaplasia occurs 
in approximately half of the H. pylori-colonized population, first in those subjects and at 
those sites where inflammation is most severe (Kuipers et al., 1995). The risk for atrophic 
gastritis depends on the distribution and pattern of chronic active inflammation. As such, 
subjects with decreased acid output show a more rapid progression towards atrophy (kuipers 
et al., 1996). Areas of gland loss and intestinal metaplasia extend with time multifocally, and 
although they do not give rise to any specific symptoms, they increase the risk for gastric 
cancer by 5- to 90-fold depending on the extent and severity of atrophy (Sipponen et al., 
1985). 
Evidence that H. pylori increases the risk of gastric cancer development via the sequence of 
atrophy and metaplasia originates from various studies, in which it was shown that H. pylori-
positive subjects develop these conditions more often than do uninfected controls (Kuipers, 
1998). This is supported by data that showed geographical associations between the 
prevalence of H. pylori and the incidence of gastric cancer (Forman et al., 1990, The 
Eurogast Study Group, 1993). The risk of development of atrophy and cancer in the presence 
of H. pylori is again related to host and bacterial factors, which influence the severity of the 
chronic inflammatory response. As such, the risk is increased in subjects colonized with 
cagA-positive strains (kuipers et al., 1995, Parsonnet et al., 1997), but also in those with a 
genetic predisposition to higher IL-1 production in response to colonization (El-Omar et al., 
2000). 
Gastric MALT lymphoma 
The association of H. pylori and MALToma is an established fact. The gastric mucosa does 
not normally contain lymphoid tissue, but MALT nearly always appears in response to 
colonization with H. pylori. In rare cases, a monoclonal population of B cells may arise from 
this tissue and slowly proliferate to form a MALT lymphoma. Nearly all MALT lymphoma 
patients are H. pylori positive (Eidt et al., 1994), and H. pylori-positive subjects have a 
significantly increased risk for the development of gastric MALT lymphoma (Personnet et 
al., 1994). Because of the diagnostic controversies and the relative rarity of this disorder, the 
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exact incidence in H. pylori-positive subjects is unknown, but MALT lymphomas occur in 
less than 1% of H. pylori-positive subjects (Parsonnet and Isaacson, 2004). 
Gastro-esophageal reflux disease (GERD) 
Yet another highly controversial topic is the role of H. pylori in the pathogenesis of gastro-
esophageal reflux disease (GERD). Some studies suggest that H. pylori protects human 
subjects from developing GERD (Blasher, 1998), whereas others postulate a causative 
association between them. Some studies have identified an association between the CagA-
positive strains and the increased acid secretion that in turn leads to gastro-esophageal reflux 
(Fallone et al., 2000). The causative association between H. pylori and GERD needs further 
research for confirmation. 
Extragastroduodenal disorders 
H. pylori has been linked to a variety of extragastric disorders. These include coronary heart 
disease, dermatological disorders such as rosacea and idiopathic urticaria, autoimmune 
thyroid disease and thrombocytopenic purpura, iron deficiency anemia, Raynaud's 
phenomenon, scleroderma, migraine, and Guillain-Barré syndrome. The underlying 
hypothetical mechanisms include chronic low-grade activation of the coagulation cascade, 
accelerating atherosclerosis, and antigenic mimicry between H. pylori and host epitopes 
leading to autoimmune disorders (Gasbarrini et al., 2004). 
Growth faltering in children 
Several studies have shown that H. pylori infection in childhood is associated with growth 
faltering (Goggin et al., 1997; Correa et al., 2006). However, these studies are confounded by 
the coexistence of variables such as poor socioeconomic status, which may contribute to both 
the development of malnutrition and the early H. pylori colonization. Therefore, H. pylori 
and growth faltering may be mere associations rather than cause and effect. 
 
Diagnosis of H. pylori infection 
Testing for H. pylori infection has become a very important part of the diagnostic process for 
gastric and duodenal inflammatory disease, since the presence or absence of infection 
determines the type of treatment to be applied. Testing is also a useful means of monitoring 
the effectiveness of courses of antimicrobial treatment. Various tests have been developed for 
the detection of H. pylori, each with their specific advantages and disadvantages (Table 2.4). 
 
Evaluation of Helicobacter pylori stool antigen detection test  
 
Table 2.4: Diagnostic methods for detection of H. pylori infection 
 Diagnostic method Sensitivity 
and 
specificitya 
Typical application Remarks 
Invasive methods 
Histology >95% “Gold standard” in 
routine hospital 
diagnostics 
Requires expert pathologist; also 
provides histological data on 
inflammation and atrophy 
Culture biopsy >95% Alternative gold 
standard 
Allows for testing of antimicrobial 
sensitivity; requires specific 
microbiological expertise 
Rapid urease (CLO) 
test 
>90% Cost-effective and 
rapid test 
Requires an additional test for 
confirmation of H. pylori infection  
Noninvasive methods  
 
Urea breath test >95% Alternative gold 
standard 
Very useful, reliable test to 
evaluate success of eradication 
treatment of H. pylori; limited 
availability due to requirement of 
expensive equipment  
Fecal antigen test >90% Not widely used yet Simple test and may be reliable 
for evaluation of success of 
eradication treatment of H. pylori 
Serology 80-90% Mainly used for 
epidemiological 
studies 
Insufficient reliability for routine 
screening; cannot prove ongoing 
infection due to immunological 
memory 
                                              a Global range, depending on regional variations and subjects. 
The available tests are generally divided into invasive tests, based on gastric specimens for 
histology, culture, or other methods, and noninvasive tests, based on peripheral samples, such 
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as blood, breath samples, stools, urine, or saliva for detection of antibodies, bacterial 
antigens, or urease activity.  
Generally, biopsy cannot be justified unless one wishes to isolate the organism for antibiotic 
sensitivity testing or there is a clear clinical indication for UGIE. If one opted to test for H. 
pylori by biopsies with UGIE, it needs a specimen from multiple regions of the stomach, 
including antrum, body and transitional zones (i.e., cardia and incisura). 
Several factors, including the need for endoscopy, pretest probability of infection, local 
availability, and an understanding of the performance characteristics of the individual tests, 
influence choice of evaluation for an individual patient. 
Invasive methods 
The collection of biopsy specimens from inflamed or ulcerated regions of the stomach and 
duodenum during invasive endoscopy is considered to be the reference method for 
diagnosing H. pylori infection. The biopsy material can be examined using one, or more, of 
three different test methods. 
Culture 
H. pylori can be cultured only when a specimen containing the pathogen has been obtained, 
and in this case that means obtaining a biopsy specimen at endoscopy. Methods of culture 
vary, but in general they involve homogenizing the biopsy specimen and culturing the 
homogenate on a variety of specialized agar plates at elevated temperatures for at least seven 
days.  
Culture is generally regarded as the 'gold standard' for detecting a bacterium. For H pylori, 
however, the success of the technique depends on local technique and access to facilities, and 
can be regarded as being no more than 60 - 90% sensitive, though being 100% specific; the 
cost of each test is high (DeCross & Puera, 1992; Perez-Perez et al., 1988).  
Histology 
Histological examination of tissue biopsy samples (usually four, taken from different parts of 
the stomach lining) permits detection of the bacterium together with evaluation of tissue 
damage. Most infection can be detected with haematoxylin & eosin (H&E) stain of gastric 
tissue, but special stains like Giemsa can be used if H&E results are not conclusive.  
The sensitivity of Wright-Giemsa and Brown-Hopps stains has been shown to be 100%, 
compared with H&E (Madan et al., 1988), though histological detection of the organism has 
Evaluation of Helicobacter pylori stool antigen detection test  
 
generally been considered to have lower sensitivity at 80 - 95% with 100% specificity. The 
need for a number of biopsy specimens to be examined by experienced pathologists renders 
histology expensive, and it requires an invasive procedure.  
Rapid urease test (RUT) 
The ability of the organism to split urea using the enzyme urease is used to identify H. pylori 
in tissue biopsy specimens. A specimen is placed on a commercially available urea-
containing medium. The hydrolysis of the urea by urease brings about a color change in the 
pH-sensitive chemicals in the medium allowing the investigator to identify the presence of 
the organism. The accuracy of the test is dependent on the number of tissue specimens tested, 
the location from which the biopsy is obtained, the bacterial load and previous use of 
antibiotics and proton pump inhibitors as well as the prevalence of the infection in the 
community (Bourke and Drumm, 2004).  
In infected tissues, the change occurs within about one hour, so that the results of the RUT 
test are often available while the patient is still at the endoscopy unit, meaning that therapy 
decisions can be made immediately. Though the test itself is inexpensive, it still requires an 
invasive procedure to obtain the sample. It has 90 - 95% sensitivity and high specificity, and 
the overall cost is moderate.  
Non-invasive methods 
Several techniques for non-invasive diagnostic tests for H. pylori have been developed and 
tests based on three of these are in widespread use. 
Urea breath test (UBT) 
Urea breath test (UBT) is a simple, non-invasive test based on H. pylori urease, and a specific 
indicator of H. pylori infection (Atherton & Spiller, 1994). The procedure requires a patient 
to attend a centre fasting, to eat a standard meal and then ingest urea labelled with C-14 or C-
13. The presence of large amounts of H. pylori urease results in the production of labelled 
carbon dioxide, which is absorbed into the blood and excreted in the breath. Samples of 
breath are collected before and sometime after the ingestion of labelled urea and the amount 
of labelled carbon dioxide measured by mass spectrometry or radioactive counting. 
While quite specific, few detection systems are readily available, and they do have a 
significant capital cost. Breath samples can be sent by post to measuring centres, though this 
involves a necessary delay before results are available. Breath testing is both sensitive (at 
least 95%) and specific (at least 98%) with a moderate cost. Breath testing has the important 
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advantage of being both non-invasive, and being able to confirm H. pylori eradication about 
one month or so after treatment has ended, should that be necessary.  
Serology 
People infected with H. pylori generally have specific IgG and IgA antibodies circulating in 
their blood and these can be detected by serological tests. Tests for the detection of antibodies 
to H. pylori circulating in blood, or found in saliva, have excellent sensitivity and specificity 
of above 95% and are cheap and simple compared with invasive techniques (DeCross & 
Puera, 1992). They can give very quick results even within minutes of the first consultation, 
and are the only tests which are not likely to give false negative results in patients who have 
taken antibiotics, bismuth compounds or omeprazole in the recent past (NIH Consensus 
Conference, 1994). Because there are different strains of H pylori, antigen for antibody 
manufacture is generally prepared by using preparations from several different strains. 
Antibody assays in blood have measured IgG and IgA antibodies which have been shown to 
be specific for H. pylori and not other gram-negative organisms. Where both IgG and IgA 
assays have been compared with other testing methods, like culture and/or histology, IgG 
assays tend to have slightly higher sensitivity and specificity, and so anti-IgG methods tend to 
be favoured (Perez-Perez et al., 1988). The commercially available assays are of two sorts: 
either microtitre-plate assays for use in a laboratory, or near-patient testing devices. Both 
types of assay usually have a cut-off value set with control sera so that they differentiate 
patients with H. pylori infection from those who do not, rather than quantify the 
concentration of circulating anti-H. pylori immunoglobulin. Laboratory based microtitre 
assays and near-patient testing devices perform equally well compared with standard 
techniques.  
Antibody tests have high sensitivity and specificity when compared with other methods. They 
also have the advantage of being non-invasive, and near-patient versions are available which 
can produce results from a small finger prick of blood within a few minutes. The costs of 
antibody tests (bedside or laboratory) are much lower than any other method.  
At least one commentator has suggested that for H. pylori infection, serology testing may be 
the "gold standard" (Blaser, 1990). Essentially, every person whose gastric biopsy can be 
shown to harbour H. pylori has evidence of a systemic humoral immune response. Those in 
whom the organism cannot be detected by other methods have a low false positive rate by 
serology. However, gastritis can be a patchy phenomenon and histologic biopsy and culture 
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assess only a small area of the stomach, while serology in essence assays the entire stomach. 
"False-positive" serology may well, in fact, reflect falsely negative biopsy results.  
Stool Antigen Test 
Recently, new tests for H. pylori infection have been developed that rely on the detection of 
specific antigens in the stools of infected individuals. The Helicobacter pylori Stool Antigen 
test (HpSA) is an enzyme immunoassay.  The initially developed stool antigen test was a 
polyclonal antibody test (Premier Platinum HpSA test; Meridian Diagnostic Inc., Cincinnati, 
OH, USA) and was found to have variable sensitivities and specificities for the diagnosis of 
H. pylori infection. The development of a new ELISA test using monoclonal antibodies 
(Femtolab H. pylori; Connex, Martinsried, Germany) gave a new dimension and greater 
precision for stool antigen testing. In comparative studies, stool antigen test using monoclonal 
antibodies showed a higher sensitivity than the polyclonal test (This et al., 2000). This test 
has demonstrated sensitivities, specificities and positive and negative predictive values of 
98%, 99%, 98% and 99%, respectively (Konstantopopulos et al., 2003) proving that 
monoclonal stool antigen enzyme immune assay is an excellent tool in diagnosing H. pylori 
infection and confirming eradication.  
H. pylori antigen detection in stool is a rapid, non invasive, easy to perform test that can be 
used to detect active infection, monitor effectiveness during therapy and to confirm cure after 
antibiotic use (Vaira et al., 2002). The ease to collect the specimen, especially in children, in 
whom endoscopy would be difficult and the non requirement of specially trained staff to 
collect and perform the test adds to the tests advantage. Also, prior preparation of the patient 
is not necessary unlike in upper gastrointestinal endoscopy. The sensitivity and specificity of 
this test to the other detection methods of H. pylori have been confirmed and documented 
(Vaira et al., 2000). HpSA has a 95% correlation with reference methods such as endoscopy, 
histology and urea breath test. It is more developed as alternative to the urea breath test 
(Gisbert et al., 2006). 
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MATERIALS AND METHODS 
The present study was carried out on 92 consecutive adult patients attending the Department 
of Gastrointestinal, Hepatobiliary and Pancreatic Diseases (GHPD) of BIRDEM General 
Hospital for diagnostic endoscopy. 
Written informed consent was obtained from all cases. The research study was approved by 
the ethics committee of BRAC University. 
Place of the study: 
All laboratory works were carried out in the Ibrahim Medical College, BIRDEM, Dhaka. 
Study Period: 
The study was conducted during the period of July’ 2012 to February’ 2014. 
Study Design: 
This was a cross sectional study.  
Study population: 
Inclusion criteria: 
i. Patients having gastrointestinal complaints, mainly dyspeptic symptoms (as 
nausea, vomiting and epigastric pain) will be included. 
Exclusion criteria:  
i. Patients with hepatic, pulmonary, renal and cardiac diseases,  
ii. Patients who undergone partial or complete gastrectomy,  
iii. Those with a prior H. pylori eradication therapy, 
iv. Those who were treated with any antibiotics, colloidal bismuth compounds, proton 
pump inhibitors (PPI), or H2 blocker within the last four weeks.  
 
Control:  
Another 31 infants aged 1 day to 30 days was enrolled from SCABU (Special Care Baby 
Unit) of BIRDEM General Hospital-2 as disease control. Stool sample was collected from 
those infants to detect H. pylori antigen (Ag). 
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Collection of samples:  
Gastric biopsy 
While diagnostic upper gastrointerstinal endoscpic examination was done, the endoscopic 
findings were recorded and one piece of gastric biopsy was taken for rapid urease test 
(RUT). 
Blood  
For detection of H. pylori antibodies 2.5 ml blood was collected from the patients. After 
collection, blood was kept at room temperature for at least half an hour followed by 
centrifugation at 1500 rpm for 10 minutes. The serum was aliquoted into microcentrifuge 
tube and stored at –20°C. Later on the serum was used for detection of anti H. pylori 
antibodies.  
Stool 
Stool sample was collected from each patient and control in a clean, dry, waterproof 
container containing no detergent, preservatives or transport media. After collection stool 
samples were examined for H. pylori antigen within 6 hours. If test not done immediately, 
sample was stored at -20oC. 
 
Laboratory procedures:  
I. Rapid Urease Test (RUT) of biopsy specimen: 
Immediately after collection, biopsy specimen was suspended in 80% urea medium. Then the 
medium was incubated at 370C and examined after 4 hours or after over-night incubation to 
detect urease activity. Urease positive isolates changed the colour of the medium from yellow 
to pink (Owen, 1996). 
 
II. Stool antigen detection: 
a. Processing of stool: 
• For solid specimen, the cap of the specimen collection tube was unscrewed and then 
specimen collection applicator will be stabbed randomly into fecal specimen in at 
least 3 different sites to collect approximately 50 mg of feces. 
• For liquid specimen, the dropper was held vertically, the specimen was aspirated and 
then transferred 2 drops (approx 80 µL) into specimen collection tube containing 
extraction buffer.  
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Then the cap was tightened, collection tube was shaken vigorously using vortex mixer 
and then centrifuged for 5 minutes at 4000rpm. 
b. Stool antigen assay (HpSA) 
Diluted stool samples were analyzed using the ABON One step H. pylori Antigen test 
device that is a lateral flow chromatographic immunoassay for detection of H. pylori 
antigen. 
• The specimen collection tube was held upright 
• Tip of the collection tube was broken off and inverted to transfer 2 drops of extracted 
specimen to specimen wells of test device. 
• Then timer was started. 
• The result was read at 10 minutes after dispensing specimen. 
• Appearance of two distinct lines indicated positive result and one line in the control 
region indicated negative. Disappearance of control line indicated invalid result. 
 
III. Serum antibody detection by Enzyme-Linked Immunosorbent Assay 
(ELISA): 
Serum samples were tested for the presence of anti H. pylori IgG and IgA antibodies. Test 
was performed by using DRG Helicobacter pylori IgG and IgA ELISA kit according to 
manufacturer instruction.  
 
Statistical analysis 
Culture is usually considered as gold standard to detect H. pylori infection. But culture was 
not performed in our study because of our limitations. RUT and serology were done and used 
to determine disease positive and negative cases. In serology, anti-H. pylori IgG and IgA 
antibodies were examined. As exposure to H. pylori occurs at a very early stage of age (1-5 
yrs), almost all patients became positive for IgG antibody in this study. So both RUT and IgA 
positive cases were taken as “disease positive”. RUT & IgA along with stool Ag positive 
cases were “True positive”. Both RUT & IgA positive but stool Ag negative cases were 
“False negative”. Alternatively‚ thirty one infants aged between 1 to 30 days from neonatal 
ICU were taken as “disease negative” cases. It was predicted that those infants were not 
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exposed to H. pylori. Among them‚ 30 infants were stool Ag test negative. These are “True 
negative” cases. One infant found positive which indicated “False positive”. On this basis‚ 
statistical analysis was done in the study.        
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RESULTS 
The present study was carried out on 92 patients suffering from dyspepsia and other upper 
gastro intestinal tract symptoms as nausea, vomiting, epigastric pain. From these patients 
gastric biopsy specimens were taken for detection of Helicobacter pylori infection by rapid 
urease test (RUT).  In addition, stool samples were taken for the detection of H. pylori 
antigen and blood for detection of anti-H. pylori IgA and IgG antibodies. 
Simultaneously, stool samples were examined as disease control from another 31 infants aged 
from 1 day to 30 days.  
Table 4.1: Results of Rapid Urease Test (RUT) and H. pylori stool antigen (Ag) detection 
in ulcer and erosion patients (n=92). 
 
Endoscopic diagnosis 
 
Number of  cases 
Number of positivity by 
n (%) 
          RUT                                Stool Ag 
 
Ulcer                                     19                                    10 (52.63%)                    14 (73.68%) 
 
Erosion                                  73                                    30 (41.09%)                    44 (60.27%) 
 
Total                                      92                                    40 (43.48%)                     58 (63.04%) 
 
Table 4.1 shows the rate of positivity of RUT and H. pylori stool antigens (Ag) test in ulcer 
and erosion patients. Among 92 adult patients undergone endoscopic examination, 19 were 
found having ulcer and 73 having erosion. Among 19 ulcer cases, 10 (52.63%) cases were 
RUT positive and 14 (73.68%) cases were stool antigen positive. Out of 73 erosion cases, 30 
(41.09%) cases were positive by RUT and 44 (60.27%) cases were positive by Stool antigen 
test. Ulcer cases showed higher positivity in antigen detection and RUT than erosion cases. 
Among total 92 adult patients, total 40 (43.48%) cases were RUT positive and 58 (63.04%) 
cases were stool antigen positive. 
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Table 4.2: Relation of Rapid Urease Test (RUT) with H. pylori stool antigen (Ag) 
detection in ulcer and erosion patients (n= 92). 
Test  No. of cases Stool Ag positive Stool Ag negative 
 
RUT positive                  40                                     39 (97.5%)                     1 (2.5%) 
 
RUT negative                 52                                     19 (36.53%)                    33 (63.46%) 
 
H. pylori stool antigen (Ag) detection test was compared with RUT in Table 4.2. Among 40 
RUT positive cases, 39 (97.5%) cases were stool antigen positive. Only 19 (36.53%) cases 
were stool antigen positive out of 52 RUT negative cases. 
 
Table 4.3: Positivity of anti-H.pylori serum IgA and IgG antibodies in ulcer and erosion 
patients (n=92). 
 
Endoscopic 
diagnosis 
 
No of 
cases 
Number of positivity by 
n (%) 
Serum IgG                 Serum IgA         Both Serum IgG & IgA 
 
Ulcer                              19                     19 (100%)                 12 (63.16%)             12 (63.16%) 
 
Erosion                          73                     70 (95.89%)              46 (63.01%)              45(61.64%) 
 
Total                              92                     89 (96.74%)              58 (63.04%)          57 (61.96%) 
 
Serum from 92 adult patients having ulcer and erosion were examined for anti- H. pylori IgA 
and IgG antibodies and shown in Table 4.3. All 19 (100%) ulcer cases were positive for anti 
H. pylori IgG and 12 (63.16%) for IgA. Total 12 (63.16%) cases were positive for both IgG 
and IgA out of 19 ulcer cases. On the other hand, among 73 erosion cases 70(95.89%) cases 
were positive for anti H. pylori IgG and 46 (63.01%) cases for IgA. Total 45 (61.64%) 
erosion cases were positive for both IgG and IgA. Among 92 cases, IgA antibody was 
positive in 58 (63.04%) cases and IgG antibody was in 89 (96.74%) cases and both antibodies 
were present in 57 (61.96%) cases.  
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Table 4.4: Relation of Rapid Urease Test (RUT) with serology in ulcer and erosion 
patients (n= 92). 
 
 
Test 
No. of 
cases 
Number of positivity by 
n (%) 
Serum IgG           Serum IgA                Both IgA and IgG 
 
RUT positive             40                39 (97.5%)             26 (65%)                          25(62.5%) 
 
RUT negative            52               50 (96.15%)           32 (61.54%)                      31(59.62%)  
 
 
Relationship between RUT and serology is showed in Table 4.4. Out of 40 RUT positive 
cases, 39 (97.5%) cases were IgG positive and 26 (65%) cases were IgA positive. Among 52 
RUT negative cases, 50 (96.16%) were positive for IgG and 32 (61.54%) were positive for 
IgA. Both antibodies were present in 25 (62.5%) cases among 40 RUT positive cases and 31 
(59.62%) cases among 52 RUT negative cases.  
 
Table 4.5:  Comparison of stool antigen (Ag) detection with serum anti H. pylori IgA 
and IgG in ulcer and erosion patients (n= 92). 
 
Comparison of stool antigen detection test with serology (Table 4.5) reveals, among 58 stool 
antigen positive cases, 57 (98.27%) were positive for IgG and 39 (67.24%) were for IgA. On 
the other hand, 32 (94.11%) were positive for IgG and 19 (55.88%) were positive for IgA out 
of 34 stool antigen negative cases. Among 58 stool antigen positive cases, 38 (65.52%) cases 
were positive for both IgA and IgG antibodies and 19 (55.88%) cases were positive for both 
antibodies out of 34 negative cases. 
 
Test 
No. of 
cases 
Number of positivity by 
n (%) 
Serum IgG            Serum IgA             Both serum IgG & IgA 
 
Stool Ag positive         58                57 (98.27%)            39 (67.24%)            38 (65.52%) 
 
Stool Ag negative        34                32 (94.11%)            19 (55.88%)            19 (55.88%) 
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Table 4.6: Mean antibody titre (IgA and IgG) in stool antigen (Ag) positive and negative 
cases. 
 
Stool Ag 
 
No. of cases 
Mean titre ± SD 
Serum IgG                                       Serum IgA 
 
Positive                               58                       2.09 ± 0.46                                       1.40 ± 1.01 
 
Negative                             34                       1.94 ± 0.52                                       1.23 ± 0.95 
 
Mean antibody titre was measured in stool antigen (Ag) positive and negative cases and 
showed in Table 4.6. In 58 stool Ag positive cases, IgG mean titre was (2.09 ± 0.46) and IgA 
mean titre was (1.40 ± 1.01).  IgG mean titre was 1.94 ± 0.52 and IgA mean titre was 1.23 ± 
0.95 in 34 stool Ag negative cases. 
 
Table 4.7: Positivity of H. pylori stool antigen in 31 neonates taken as control. 
 
Stool Ag detection Result of H. pylori stool Ag 
 No                                                             % 
 
Positive                                           1                                                             3.23 
 
Negative                                        30                                                            96.77 
 
H. pylori stool antigen positivity of 31 infants as control is showed in Table 4.7. Among 31 
infant stool samples, 1 (3.23%) was positive for stool antigen and 30 (96.77%) were negative 
for stool antigen. 
 
 
 
 
 
 
Evaluation of Helicobacter pylori stool antigen detection test  	
 
Table 4.8: Performance of the H. pylori stool antigen assay (HpSA) method. 
Test          Sensitivity       Specificity           PPV               NPV                     Diagnostic accuracy 
                      (%)                  (%)                   (%)                (%)                                   (%)     
 
 
HpSA            100                   96.77               96.30               100                               98.25 
 
PPV = Positive predictive value.  
NPV = Negative predictive value. 
 
Performance of the (HpSA) method for H. pylori stool antigen detection (Table 4.8) in shows 
that the HpSA method for antigen detection had a sensitivity of 100% and specificity of 
96.77%. Positive and negative predictive values of the HpSA method were 96.30% and 100% 
respectively. The diagnostic accuracy of the test was 98.25%. 
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DISCUSSION 
Helicobacter pylori (H. pylori) is a major causative agent of several gastro-duodenal 
pathologies like chronic gastritis and peptic ulcer disease (Rauws and Tytgat, 1990). 
Furthermore, H. pylori plays a pivotal role in the pathogenesis of gastric cancer and gastric 
mucosa-associated lymphoid tissue (MALT) lymphoma (Asghar and Parsonnet, 2001). The 
severity of the inflammation is likely to underlie H. pylori-related diseases (Fock and Ang, 
2010). 
As the eradication of H. pylori has been shown to improve the outcome of peptic ulcer 
disease in terms of recurrence and complications, the accurate diagnosis of H. pylori infection 
is essential for the effective treatment and management of infection caused by H. pylori. 
Numerous invasive and noninvasive diagnostic tests have been developed. Each of the 
techniques has advantages as well as disadvantages which will make it more or less 
appropriate depending on the clinical situation. It is now clear that the discussion over the 
different diagnostic methods cannot be oversimplified by reasoning only in term of which is 
the best diagnostic tool. (Chong, 2007; Iwanczak et al., 2005). 
In the present study RUT, serology and H. pylori stool antigen (HpSA) test were used as 
diagnostic tools. The choice of diagnostic tests to determine H. pylori infection status 
depends on the sensitivity, specificity, reproducibility, availability, and rapidity of the results 
as well as the cost of the tests (Megraud, 1996). Unfortunately, none of the currently used 
methods can fulfill this criterion. One solution is to combine results of two or more 
techniques considered to be reliable, and compare with results of the method being evaluated. 
Culture is usually considered as the gold standard for the diagnosis of any microorganism, 
but culture was not done in this study because of many drawbacks including that the 
microorganism is slow-growing, fastidious. Also it is time consuming and difficult to grow 
due to the usual non-abundance of bacteria and the strict conditions required for its growth 
like growth supplements and selective requirements (Hazell et al.,  1989; Heatly, 1995) . 
  
Rapid urease test (RUT) of gastric biopsy material is the commonly used method to diagnose 
the presence of H. pylori by urease activity (Marshall et al., 1987; Hazell et al., 1987). In this 
study, Stool antigen (Ag) test (HpSA) was compared with serology and RUT. 
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In the present study after endoscopic examination of dyspeptic patients, 19 ulcer cases and 73 
erosion cases were included. RUT was positive in 10 (52.63%) cases out of 19 ulcer cases. 
Among 73 erosion cases‚ 30 (41.09%) cases were found positive for RUT test (Table 4.1). 
So it is clearly evident that ulcer cases were more RUT test positive than erosion cases. The 
overall RUT positive cases were 40 (43.48%). This finding is in harmony to the study done in 
Kuwait University, where 52% of the patients had a positive RUT test when they also used a 
single antral biopsy as we did (Siddique et al., 2008). Akanda and Rahman (2011) also 
detected H. pylori by RUT in 56.4% case which is in agreement with our finding. However, 
our result was different from that of Refaay et al.‚ (2006) who found 70% RUT positivity 
which is higher than our study. This may be due to the fact that in the RUT, false-negative 
results may occur because of irregular distribution of bacteria in the gastric mucosa 
(Chattopadhyay et al., 2005). So more than one biopsy specimen should be taken for getting 
more accurate result.  But in the present study only a single biopsy was available which may 
influence the result.       
In populations where H. pylori prevalence is high (≥ 20-25 percent), patients should be tested 
for H. pylori non-invasively, and given treatment to eradicate H. pylori. Regarding 
noninvasive techniques, the present study showed that stool antigen assay (HpSA) has 
produced promising results for the detection of H. pylori antigen in stool samples. This 
technique gave higher positivity in detecting H. pylori infection than RUT.  H. pylori antigen 
was detected in 63.04% cases. Ulcer patients showed more positivity (73.68%) in antigen 
detection than erosion patients (60.27%) (Table 4.1). The result was comparable to that of 
Nermin et al.‚ (2012) who stated that 66.7% of patients were found positive by testing their 
stool for H. pylori antigens. Refaay et al.‚ (2006) found higher positivity (70%) in H. pylori 
stool antigen with a sensitivity of 83.3%. They also found that ulcer cases show more stool 
antigen positivity (80%) than erosion cases (41.7%) (Rafaay et al., 2006). From our study it 
is obvious that positivity by RUT and Stool Ag was higher in ulcer patients than erosion 
patients. So ulcer patients can be strongly suspected as H. pylori infection and be treated 
thereby. Simultaneously positivity of H. pylori infection should be carefully evaluated in 
patients having erosion in endoscopy for further evaluation. Regarding total samples‚ 
sensitivity of stool Ag was found to be higher than RUT both in ulcer and erosion cases.  
 In the present study‚ out of 40 RUT positive cases only one was stool Ag negative‚ rest 39 
cases were found positive Stool Ag tests (HpSA). So it reveals that stool Ag test can 
efficiently detect H. pylori infection. Furthermore‚ among RUT negative cases 36.53% cases 
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were stool Ag positive (Table 4.2). It further emphasizes the higher sensitivity of Ag 
detection. 
Pathological mechanism of H. pylori infection is associated with immunopathological 
response of host. When chronic gastritis occurs, a detectable specific humoral immunological 
response is established. The appearance of serum antibodies such as IgG and IgA may 
indicate an extensive immunoreactions caused by H. pylori infection.  
In H. pylori infected patients, first IgM class antibodies develop. Then, both systematically 
and locally in gastric mucosa, IgG and IgA antibodies develop (Fox and Megraud, 2009). 
Sampling of gastric secretions from H pylori–infected individuals reveals a robust mucosal 
antibody response, primarily of the IgA isotype (Rathbone et al., 1986). Most patients 
infected with H. pylori produce a measurable systemic immune response, composed 
primarily of IgG (Perez-Perez et al., 1988). The levels of antibodies increase with age with 
the highest increases seen for IgG early during childhood and for IgA between childhood and 
adulthood.  But circulating anti–H. pylori IgG antibodies persist at constant levels for years 
during infection and it′s titers also lasts for long periods of time after eradication of the 
infection. In contrast to serum IgG titers‚ IgA titers rise rapidly after infection and decrease if 
the infection is cleared. In addition‚ adults have about 15-fold higher IgA titers and 3-fold 
higher IgG titers than infants (Bhuiyan‚ 2010)  
Serum IgA may be detected in variable ranges (39%-82%) of infected patients, and serum 
IgM is found rarely. These findings are consistent with a chronic infection usually acquired in 
early childhood. Assays to detect anti–H. pylori IgA in serum samples have variable 
sensitivities (39%-82%) compared with serum IgG immunoassays. Serum IgA studies may be 
useful in testing of symptomatic individuals with equivocal or negative IgG findings. In one 
study, more than 7% of patients with negative serum IgG results were found to have 
detectable anti–H. pylori serum IgA and symptoms consistent with H. pylori infection. Of 6 
patients with IgA-positive, 5 had peptic ulcers documented by endoscopy (Jaskowski, 1997). 
Nystrom et al.‚ observed a direct relation between protection and IgA levels in the stomach 
(Nystrom et al.‚ 2006). So‚ IgA positivity emphasizes the incidence of current infection.  
In this thesis, serum anti- H. pylori IgA antibody was detected in 63.04% case and IgG 
antibody in 96.74% cases. Both antibodies were detected in 61.96% cases (Table 4.3). The 
percentage of serum IgG is very high because almost all the children get infected with H. 
pylori during their early childhood (Mahalanabis et al.‚ 1996; Clemens et al.‚ 1996). It is also 
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found that all IgA positive cases are also positive for IgG. So it clearly indicates current 
infection. Oluwasola et al.‚ (2012) also reported anti-H. pylori IgA positivity in 67.7% cases. 
Sharma et al.‚ (2012) also found 68.5% positivity by IgA serology. The anti-H. pylori IgA 
prevalence of our dyspeptic patients is similar to the values found in other studies for 
developing countries (Futagami et al., 1994; Kosunen et al., 2005). In the presence of IgG, 
IgA has been shown to correlate with active infection in 95% and 74% of cases of duodenal 
and gastric ulcers, respectively (Granberg et al., 1993). Yamamoto et al.‚ (1995) found a 
significant association between serum IgA titres and the development of atrophic gastritis. Li 
et al.‚ (2003), on the other hand found that in the absence of histological diagnosis of H. 
pylori in the gastric mucosa in chronic gastritis anti-H. pylori serum IgA is significantly 
higher in patients with severe intestinal metaplasia than in those with mild intestinal 
metaplasia. Increases in IgA titer against H. pylori antigens during active infections have 
been reported. IgA antibodies to H. pylori and low levels of pepsinogen I in patients’ sera 
increase the risk of gastric carcinoma (Aromaa et al., 1996) 
In the current study, almost all patients were found to be positive for IgG irrespective of RUT 
Stool Ag test status but IgA positivity was found to lower number of patients. It is obvious 
from our study, 62.5% case was positive for RUT & both antibodies. In addition, 65.52% 
case was positive for stool Ag & both antibodies. These were considered as true infection. 
Other than these, 59.62% RUT negative cases and 55.88% stool Ag negative cases were 
found positive for both antibodies. These cases should be carefully diagnosed by other 
methods or monitored for response after treatment (Table 4.4 & 4.5). 
The higher percentage of IgG positivity may be due to IgG is the predominant circulatory 
antibody than IgA and hence indicate that the predominant local production of IgA does not 
lead to high systemic IgA antibody levels in all patients.  The same percentage of IgA and 
IgG seropositivity among RUT and stool Ag negative patients found may be due to the fact 
that IgG seropositivity may continue for many years, even proper antibiotics are used (Alim 
et al., (2010). Futagami et al.‚ (1998) reported that the IgA response of gastric mucosa in 
chronic gastritis patients can be detected even in the quiescent period of negative H. pylori 
infection due to the recent exposure to the bacterial antigens. 
 
It also appears in our study that sensitivity of IgA antibody and stool Ag test is almost equal 
which is much higher than RUT (Table 4.1 & 4.3). This is supported by the result of Bhuiyan 
who observed that stool antigen test and IgA detect H. pylori infection almost at the same rate 
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and up to 90% of adults from Dhaka in Bangladesh were positive for H. pylori, assessed by 
stool antigen test and serologic anti- H. pylori IgA antibody. (Bhuiyan‚ 2010). 
In our current study, IgA antibody mean titres were 1.40±1.01 and 1.23±0.95 in stool Ag 
positive and negative cases respectively. On the other hand‚ IgG antibody titre were 
2.09±0.46 and 1.94±0.52 in case of Stool Ag positive and negative patients respectively 
(Table 4.6). There is no significant difference between IgA and IgG antibody titre among 
stool Ag positive and negative patients.  
Culture is usually taken as gold standard to determine H. pylori infection. In the current 
study‚ culture was not carried out because of some limitations (e.g. it is slow growing‚ 
fastidious‚ require special medium & environment etc). Therefore, to determine specificity of 
the stool antigen test (HpSA), stool samples were collected from 31 neonates. These neonates 
were considered as ‛Disese negative’ cases because yet they were not exposed to H. pylori. 
Of 31 neonates stool samples, only one (3.23%) neonate was positive for H. pylori stool 
antigen test (Table 4.7). Fujimura et al.‚ (2004) also found that stool antigen test was positive 
for 2% neonate with a positive PCR. Stray-Pedersen et al.‚ (2007) detected H. pylori stool 
antigen in 15% neonates aged 7 days-1 month. These findings are similar to our study. 
 
The sensitivity, specificity and diagnostic accuracy of HpSA test were 100%, 96.77% and 
98.25% respectively (Table 4.8). The specificities of serum IgA were higher than serum IgG 
in relation to stool antigen test (73-98% for IgA and 47-77% for IgG) (Bhuiyan‚ 2010). A 
systematic review of the stool antigen test in untreated patients with H. pylori demonstrated 
overall sensitivity of 91%, specificity of 93%, and positive and negative predictive values of 
92% and 87%, respectively (Gisbert and Pajares, 2004). A prospective multicentre European 
study evaluated the accuracy of the HpSA for active H.pylori infection in 501 patients, the 
results were compared to those obtained with invasive tests requiring endoscopy (RUT, H&E 
and the culture) and the non-invasive UBT. Several studies with HpSA in various regions of 
the world have shown comparable sensitivities (91-98%) and specificities (83-100%) (Kabir, 
2003; Andrews et al., 2003; Gisbert and Pajares, 2001).  
The noninvasive enzyme immunoassay HpSA is a quick and cost effective method. It does 
not require specialized expertise. The analytical technique of the immunoassay in stool 
samples can be performed easily in any laboratory. The test can be performed in conjunction 
with other diagnostic procedures. Feces can be obtained easily, even in new born children. 
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Spot samples of the stool are sufficient. Homogenization of the stool is not required. Previous 
studies have reported that a biopsy-based test has a lower detection rate for H. pylori in the 
presence of gastric atrophy (Yoo et al., 2007; Shin et al., 2009). The performance of a new 
stool antigen test on the other hand was comparable to that of other methods in the diagnosis 
of H. pylori infection for the screening population, even with the presence of atrophic 
gastritis/ intestinal metaplasia (Choi et al., 2011). Besides, it has been claimed that HpSA can 
be used for monitoring treatment success and that successful eradication of H. pylori can be 
confirmed after treatment (Arents et al., 2001). For abovementioned reasons, this method is 
more suitable for screening and epidemiological studies. 
In conclusion, the study showed that highly sensitive and specific HpSA can be a reliable 
alternative to other techniques for diagnosing active H. pylori infection in non treated 
patients. It can be considered as a noninvasive first-line routine diagnostic test in our region. 
HpSA may be useful particularly in selection of the cases requiring endoscopic examination, 
in monitoring the response to treatment and in epidemiological studies. 
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Appendices 
Appendix 1 
Patients’s questionnaire form 
 
 Date: 
 Sample No: 
1. Patients’s personal information: 
Name:                                                                       Age: 
Sex:                                                                                           Contact No:                                                                
2. Patient type:  
In Door:                                                                            Out Door: 
3. Illness type and history: 
4. Endoscopic finding: 
Ulcer:                                       Erosion:       
5. Sample collection: 
Sample type: Biopsy, stool & Blood 
 
Appendix 2 
Calculation of Sensitivity, Specificity, PPV, NPV & Diagnostic accuracy: 
 
                            True positive 
Sensitivity= —―—―—―—―—―—―—― × 100 
                                  True positive + false negative 
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                            True negative 
Specificity= —―—―—―—―—―—―—― × 100 
                                  False positive + true negative 
                            True positive 
PPV = —―—―—―—―—―—―—― × 100 
                       True positive + false positive 
 
 
 
                            True negative 
 NPV = —―—―—―—―—―—―—― × 100 
                       True negative + false negative 
 
 
                                           True positive + True negative 
Diagnostic accuracy = —―—―—―—―—―—―—――—―—―—――—―—× 100 
                                                   True positive + False positive + False negative+ True negative 
 
 
Appendix 3 
Rapid Urease Test (RUT) 
RUT requires MIU (Motility Indole Urea) medium. Test simultaneously checks for the 
production of indole, Urea hydrolysis and bacterial motility.  
Composition of MIU base: 
Ingredients Amount 
Proteose Peptone Difco 10.0g 
Beef extract  5.0g 
NaCl 5.0g 
KH2PO4 2.0g 
Phenol red solution (1/500) 6 ml 
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Agar 3.0g 
Distilled Water 900 ml 
                                                          PH= 6.8-6.9 
 
Preparation of Urea solution: 
Eight gram (8g) Urea powder was dissolved in 10 ml DW to make 80% urea solution. Then 
urea solution was sterilized using filtered using milipore filter. 
 
MIU media preparation: 
1.8g MIU base powder was dissolved in 95 ml distilled water in a conical flask 
                                        │ 
Then heated to melt all the ingredients 
                                        │ 
MIU base medium is autoclaved at 121oC under 15 lb/in2 for 15 minutes and then cooled 
to about 500C  
                                         │ 
5 ml urea solution was added to 95 ml MIU base medium 
                                         │ 
Then sorted into small bottle before hardening 
                                          │ 
Final medium was semi-solid and kept in refrigerator 
 
 
                                      MIU Medium sorted in small bottle 
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RUT procedure: One piece of antral biopsy is placed into semi solid MIU medium and then 
incubated overnight at 370C. Positive result changed the color of medium from yellow to 
pink. 
 
 
Appendix 4 
ELISA Procedures: 
1. Assay Procedure of IgG ELISA 
 
 
Reagent Preparation 
 
Wash Buffer dilution----1 vol. Wash Buffer: 19 vol. DW 
 
Sample dilution 
Prepare 1:40 dilution for test samples, all six H. pylori standards, low control, and high 
control by adding 5 µl of the sample to 200 µl of sample diluent. 
 
Assay Procedure of IgG ELISA 
 
Secure the desired number of coated wells in the holder 
↓ 
For the reagent blank, dispense 100µl sample diluent in A1well position 
↓ 
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Dispense 100 µl of diluted sera, 1 standard, and controls into the appropriate wells 
↓ 
Tap the holder to remove air bubbles from the liquid and mix 
well for 10 seconds. 
↓ 
Incubate at room temperature for 30 minutes 
↓ 
Remove liquid from all wells 
↓ 
Rinse and flick the microtiter wells 4 times with diluted wash buffer and then one time with 
distilled water 
↓ 
Dispense 100 µl of enzyme conjugate to each well 
                                                                           ↓ 
Mix gently for 10 secoonds. 
↓ 
Incubate at room temperature for 30 minutes 
↓ 
Remove enzyme conjugate from all wells 
↓ 
Rinse and flick the microtiter wells 4 times with diluted wash buffer and then one time with 
distilled water 
↓ 
Add 100 µl of TMB Reagent to each well  
                                                                           ↓ 
Mix gently for 10 seconds 
↓ 
Incubate at room temperature for 20 minutes 
↓ 
Add 100µl of Stop Solution to each well including the 2 blanks 
                                                                           ↓ 
Mix gently for 30 seconds 
↓ 
Read the optical density at 450 nm within 15 minutes 
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Figure: Anti-H. pylori IgG ELISA 
 
II. Assay Procedure (IgA ELISA) 
Select the required number of microtiter strips or wells and insert them into the holder 
↓ 
Leave well A1 for substrate blank 
↓ 
Dispense 
100 µL of Neg. Control into well B1 
100 µL of Standard 1 into well C1 
100 µL of Pos. Control into well D1 
↓ 
100 µL of each diluted sample into appropriate wells. 
↓ 
Incubate for 60 minutes at 37 °C covering wells with foil 
↓ 
Briskly shake out the contents of the wells. 
↓ 
Rinse the wells 5 times with diluted Wash Solution 
↓ 
Strike the wells sharply on absorbent paper. 
↓ 
                                 Dispense 100 µL Enzyme Conjugate into each well, except A1. 
↓ 
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Incubate for 30 minutes at RT covering the wells 
↓ 
Briskly shake out 
↓ 
Rinse the wells 5 times with diluted Wash Solution 
↓ 
Strike the wells sharply on absorbent paper 
↓ 
Add 100 µL of Substrate Solution into all wells 
↓ 
Incubate for exactly 15 minutes at RT in the dark 
↓ 
Add 100 µL of Stop Solution to each well 
↓ 
Blue color turns into yellow 
↓ 
Read the OD at 450/620 nm within 30 minutes 
 
 
 Figure:Anti- H. pylori IgA ELISA 
